BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34805743)

  • 1. Treatment Patterns, Outcomes, and Costs Associated With Localized Upper Tract Urothelial Carcinoma.
    Fero KE; Shan Y; Lec PM; Sharma V; Srinivasan A; Movva G; Baillargeon J; Chamie K; Williams SB
    JNCI Cancer Spectr; 2021 Dec; 5(6):. PubMed ID: 34805743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic Management of Low-Grade Upper Tract Urothelial Carcinoma: Characterizing the Long-term Burden of Care in Comparison to Radical Nephroureterectomy.
    Shenhar C; Veredgorn Y; Bulis S; Aviv T; Darawsha AE; Gilad R; Baniel J; Ehrlich Y; Lifshitz D
    Urology; 2022 Jan; 159():152-159. PubMed ID: 34536409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urothelial Carcinoma of the Renal Pelvis and Ureter: Does Location Make a Difference?
    Lwin AA; Hsu CH; Chipollini J
    Clin Genitourin Cancer; 2020 Feb; 18(1):45-49.e1. PubMed ID: 31786118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is bladder preservation safe? The oncology outcomes of patients after 2-sided radical nephroureterectomies due to bilateral upper urinary tract urothelial carcinomas.
    Kao YL; Yang WH; Ou CH
    Int Urol Nephrol; 2022 Jan; 54(1):63-69. PubMed ID: 34783981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Rieken M; Xylinas E; Kluth L; Trinh QD; Lee RK; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Kautzky-Willer A; Bachmann A; Shariat SF;
    Eur J Surg Oncol; 2014 Jan; 40(1):113-20. PubMed ID: 24113620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laparoscopic radical nephroureterectomy is associated with worse survival outcomes than open radical nephroureterectomy in patients with locally advanced upper tract urothelial carcinoma.
    Kim HS; Ku JH; Jeong CW; Kwak C; Kim HH
    World J Urol; 2016 Jun; 34(6):859-69. PubMed ID: 26497823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephroureterectomy vs. segmental ureterectomy of clinically localized, high-grade, urothelial carcinoma of the ureter: Practice patterns and outcomes.
    Piraino JA; Snow ZA; Edwards DC; Hager S; McGreen BH; Diorio GJ
    Urol Oncol; 2020 Nov; 38(11):851.e1-851.e10. PubMed ID: 32859461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laparoscopic versus open nephroureterectomy to treat localized and/or locally advanced upper tract urothelial carcinoma: oncological outcomes from a multicenter study.
    Liu JY; Dai YB; Zhou FJ; Long Z; Li YH; Xie D; Liu B; Tang J; Tan J; Yao K; He LY
    BMC Surg; 2017 Jan; 17(1):8. PubMed ID: 28095848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of perioperative outcomes between open and minimally invasive nephroureterectomy: A population-based analysis.
    Nazzani S; Bazinet A; Preisser F; Mazzone E; Tian Z; Mistretta FA; Shariat SF; Saad F; Zorn KC; Montanari E; Briganti A; Carmignani L; Karakiewicz PI
    Int J Urol; 2019 Apr; 26(4):487-492. PubMed ID: 30756440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTRF independently predicts progression and survival in multiracial upper tract urothelial carcinoma following radical nephroureterectomy.
    Yeh HC; Margulis V; Singla N; Hernandez E; Panwar V; Woldu SL; Karam JA; Wood CG; Weizer AZ; Raman JD; Remzi M; Rioux-Leclercq N; Haitel A; Roscigno M; Bolenz C; Bensalah K; Li CC; Ke HL; Li WM; Lee HY; Rapoport LM; Lotan Y; Kapur P; Shariat SF; Hsieh JT; Wu WJ
    Urol Oncol; 2020 May; 38(5):496-505. PubMed ID: 31862213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between lymphovascular invasion and oncological outcome in node-negative upper tract urothelial carcinoma with different stage.
    Chen CS; Lin CY; Wang CL; Wang SS; Li JR; Yang CK; Cheng CL; Chiu KY; Yang SF
    Urol Oncol; 2021 Feb; 39(2):132.e13-132.e26. PubMed ID: 32900630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic intervention versus radical nephroureterectomy for the management of localized upper urinary tract urothelial carcinoma: a systematic review and meta-analysis of comparative studies.
    Giulioni C; Brocca C; Tramanzoli P; Stramucci S; Mantovan M; Perpepaj L; Cicconofri A; Gauhar V; Merseburger AS; Galosi AB; Castellani D
    World J Urol; 2024 May; 42(1):318. PubMed ID: 38743260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.
    Cutress ML; Stewart GD; Wells-Cole S; Phipps S; Thomas BG; Tolley DA
    BJU Int; 2012 Dec; 110(11):1608-17. PubMed ID: 22564677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience.
    Cutress ML; Stewart GD; Tudor EC; Egong EA; Wells-Cole S; Phipps S; Thomas BG; Riddick AC; McNeill SA; Tolley DA
    J Urol; 2013 Jun; 189(6):2054-60. PubMed ID: 23228378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Consequences of Inadvertent Radical Nephrectomy in the Treatment of Upper Tract Urothelial Carcinoma.
    Al Hussein Al Awamlh B; Shoag JE; Basourakos SP; Lewicki PJ; Posada L; Ma X; Raman JD; Shariat SF; Scherr D
    Urology; 2021 Aug; 154():127-135. PubMed ID: 33766715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival outcomes for patients with localised upper tract urothelial carcinoma managed with non-definitive treatment.
    Syed JS; Nguyen KA; Suarez-Sarmiento A; Johnson K; Leapman MS; Raman JD; Shuch B
    BJU Int; 2018 Jan; 121(1):124-129. PubMed ID: 28972702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative Pyuria Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer.
    Sato G; Yoshida T; Yanishi M; Saito R; Murota T; Kawa G; Kinoshita H; Matsuda T
    Clin Genitourin Cancer; 2020 Apr; 18(2):e167-e173. PubMed ID: 31635939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degree of hydronephrosis predicts adverse pathological features and worse oncologic outcomes in patients with high-grade urothelial carcinoma of the upper urinary tract.
    Chung PH; Krabbe LM; Darwish OM; Westerman ME; Bagrodia A; Gayed BA; Haddad AQ; Kapur P; Sagalowsky AI; Lotan Y; Margulis V
    Urol Oncol; 2014 Oct; 32(7):981-8. PubMed ID: 25022858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephron-sparing management vs radical nephroureterectomy for low- or moderate-grade, low-stage upper tract urothelial carcinoma.
    Simhan J; Smaldone MC; Egleston BL; Canter D; Sterious SN; Corcoran AT; Ginzburg S; Uzzo RG; Kutikov A
    BJU Int; 2014 Aug; 114(2):216-20. PubMed ID: 24053485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant carcinoma in situ as a prognostic factor in the upper tract urothelial carcinoma after radical nephroureterectomy: A systematic review and meta-analysis.
    Gao X; Ma Y; Chen G; Chen J; Li H; Li H; Wei X; Wang K
    Urol Oncol; 2020 Jun; 38(6):574-581. PubMed ID: 32273049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.